Positive Data on Pfizer's Axitinib - Zacks.com PDF Print
Zacks.comPfizer intends to work with regulatory authorities to determine the regulatory path forward for axitinib for the renal cell carcinoma indication.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.